2 Patents
- US119985212024Use of an RXR Agonist in Treating Drug Resistant HER2+ Cancers
Board Of Regents, The University Of Texas System
0 cites - US118965582024Use of an RXR Agonist and Taxanes in Treating Her2+ Cancers
Board Of Regents, The University Of Texas System
0 cites